Autoantibodies against myelin oligodendrocyte glycoprotein in a subgroup of patients with psychotic symptoms by Nikita A. van de Burgt, Nikita A. van de Burgt, Laila Kulsvehagen, Marina Mané-Damas, Marina Mané-Damas, Luc Lutz, Anne-Catherine Lecourt, Clara Monserrat, Clara Monserrat, Anita M. Vinke, Cem İ. Küçükali, Shenghua Zong, Shenghua Zong, Carolin Hoffmann, Carolin Hoffmann, Emiliano González-Vioque, Celso Arango, Nicole K. Leibold, Nicole K. Leibold, Mario Losen, Mario Losen, Peter C. Molenaar, Peter C. Molenaar, Erdem Tüzün, Nico J. M. van Beveren, Nico J. M. van Beveren, Anna Mané, Anna Mané, Rob P. W. Rouhl, Rob P. W. Rouhl, Rob P. W. Rouhl, Therese A. M. J. van Amelsvoort, Therese A. M. J. van Amelsvoort, for Genetic Risk and Outcome of Psychosis (GROUP) Investigators, Anne-Katrin Pröbstel, Anne-Katrin Pröbstel, Anne-Katrin Pröbstel, Pilar Martinez-Martinez, Pilar Martinez-Martinez

Get full text